Delivery Order SPE2DR25D7059-SPE2DR26F7MLF
- Not listed
- The Defense Logistics Agency awarded a $46,934.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on July 18, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $5,989.62 and an ultimate completion date of October 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a $8,381.10 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on September 25, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract does not utilize a set-aside designation and...
- The Defense Logistics Agency awarded a $23,467.08 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This competitively awarded, firm fixed-price contract has a completion date of November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $33.5K to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on May 20, 2025, with an ultimate completion date of June 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Xeomin is a botulinum toxin product used for therapeutic and cosmetic applications, representing one of...
- The Defense Logistics Agency awarded a $1,472.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. The award, issued on December 1, 2025, with a completion date of December 22, 2025, represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,349.60 for 200-unit vials of Xeomin on August 26, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $14,183.70 to supply 200-unit vials of Xeomin, a botulinum toxin product used for medical purposes. The contract is a firm fixed-price delivery order with an ultimate completion date of November 21, 2025, and was awarded on October 30, 2025, through a non-set-aside competitive procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $49,461.72 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin on December 10, 2025, with a completion date of January 2, 2026. This firm fixed-price contract utilizes a competitive, non-set-aside procurement process and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $46,934.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for 200-unit vials of Xeomin, with an ultimate completion date of September 29, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MLFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin on November 26, 2025, with a ceiling value of $6,771.53. This firm fixed-price delivery order, with an ultimate completion date of December 18, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a prime contract value of $999,999,999.00 through December 2026. Xeomin, a botulinum toxin product used for therapeutic and cosmetic applications, falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio supporting military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability in delivering specialized medical products and medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the operational flexibility of the DLA Troop Support Medical contract vehicle, which enables AmerisourceBergen to fulfill specific federal medical supply requirements on an as-needed basis while maintaining consistent pricing and service standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/25/25 |